Jonathan B.
About Jonathan B.
Professional Title and Current Position
Jonathan Rubin, MD, MBA, currently holds the position of Senior Vice President and Chief Medical Officer in the Research & Development sector. In this role, he oversees medical strategies, research initiatives, and clinical developments, providing leadership and direction for the company's medical operations.
Educational Background
Jonathan Rubin earned his MD from the University of Connecticut School of Medicine. He also holds an MBA from the prestigious Columbia School of Business. Prior to these, he received his Bachelor of Science degree in molecular biophysics and biochemistry from Yale University. These qualifications provide him with a strong foundation in both medical science and business management.
Career in Medical Practice
Before transitioning into the biopharmaceutical industry, Jonathan Rubin practiced as a Developmental-Behavioral and General Pediatrician for 16 years. His clinical training includes a pediatric residency completed at Albert Einstein/Montefiore Hospital in the Bronx, New York, followed by a fellowship in ambulatory pediatrics at Boston’s Children Hospital.
Leadership Roles in Biopharmaceutical Industry
Jonathan Rubin has held several notable positions in the biopharmaceutical industry. He was the Chief Medical Officer of Atentiv, Inc. from 2018 to 2020, and Alcobra, Inc. from 2013 to 2017. Additionally, he served as a clinical consultant to Chondrial Therapeutics, Inc. from 2017 to 2018. Earlier in his career, he worked as the Medical Director of Clinical Development and Medical Affairs for Shire Pharmaceuticals from 2007 to 2013.